This is a synthetic peptide designed for use in combination with anti-HMG20B antibody (Catalog #: ARP35798_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
HMG20B
(High Mobility Group 20B (HMG20B))
Synonyme
BRAF25 Peptide, BRAF35 Peptide, HMGX2 Peptide, HMGXB2 Peptide, PP7706 Peptide, SMARCE1r Peptide, SOXL Peptide, pp8857 Peptide, AW610687 Peptide, Hmgx2 Peptide, Hmgxb2 Peptide, Smarce1r Peptide, high mobility group 20 B Peptide, high mobility group 20B Peptide, Hmg20b Peptide, HMG20B Peptide
Hintergrund
HMG20B is required for correct progression through G2 phase of the cell cycle and entry into mitosis. HMG20B is also required for RCOR1/CoREST mediated repression of neuronal specific gene promoters.